{'fraction_non_alphanumeric': 0.023614895549500452, 'fraction_numerical': 0.0036330608537693005, 'mean_word_length': 5.63855421686747, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor.

The effect of platelet-activating factor (PAF) or human peripheral-blood-derived monocytes (PBM) was examined. The addition of PAF to monocyte cultures did not activate the cells to mediate cytotoxicity activity against 51Cr-labeled target cells. Furthermore, supernatants derived from the treated cultures were not cytotoxic. However, these supernatants contained tumor necrosis factor (TNF) when assayed by a sensitive radioimmunoassay. Further kinetic studies indicated that cytotoxic supernatant is detected at 2-4 h following PAF treatment but not overnight treatment, suggesting, perhaps, the presence of inhibitors interfering with the cytotoxic activity. Cells pretreated with PAF responded poorly to a second stimulation with phorbol myristate acetate whereas a secondary response was seen with cells pretreated with interferon-gamma. These results suggest that PAF is involved in regulating cytokine production by monocytes and thus plays a role in the immune response to foreign antigens.